首页|妊娠早期进行糖脂代谢指标及凝血功能指标检测对妊娠期糖尿病的预测价值

妊娠早期进行糖脂代谢指标及凝血功能指标检测对妊娠期糖尿病的预测价值

扫码查看
目的 探讨妊娠早期进行糖脂代谢指标及凝血功能指标检测对妊娠期糖尿病(GDM)的预测价值.方法 选取126例产检的孕妇为研究对象,在孕10~13周建卡时搜集其基线资料与实验室指标,并依据孕24~28周口服葡萄糖耐量试验(OGTT)结果将其分为GDM组(n=31)和非GDM组(n=95).用单因素、多因素Logistic回归分析确定GDM的影响因素;绘制受试者工作特征曲线(ROC),分析糖脂代谢指标、凝血功能指标单独检测及联合检测对GDM的预测价值.结果 GDM组孕妇年龄(31.01±8.13)岁、孕前体质量指数(BMI)(22.13±3.91)kg/m2、孕期增重(6.58±1.39)kg、空腹血糖(FPG)(5.01±0.46)mmol/L、总胆固醇(TC)(5.33±1.11)mmol/L、低密度脂蛋白胆固醇(LDL-C)(3.96±1.28)mmol/L、小而密低密度脂蛋白(sdLDL)(418.33±16.47)mg/dl、载脂蛋白B(ApoB)(0.94±0.07)g/L、载脂蛋白E(ApoE)(44.35±1.04)mg/L、糖化血红蛋白(HbA1c)(8.83±0.52)%、D-二聚体(D-D)(0.53±0.04)mg/L高于非GDM组的(27.05±6.03)岁、(20.76±3.02)kg/m2、(5.02±1.28)kg、(4.71±0.31)mmol/L、(4.92±0.79)mmol/L、(3.11±0.96)mmol/L、(341.25±14.08)mg/dl、(0.86±0.05)g/L、(40.05±1.52)mg/L、(5.54±0.63)%、(0.49±0.03)mg/L,凝血酶原时间(PT)(11.53±0.25)s、国际标准化比值(INR)(0.97±0.05)、活化部分凝血活酶时间(APTT)(26.89±1.74)s、凝血酶时间(TT)(15.42±0.17)s低于非GDM组的(11.97±0.29)s、(1.02±0.07)、(28.11±1.83)s、(15.88±0.19)s(P<0.05);两组建档孕周、OGTT检测孕周、产次、收缩压(SBP)、舒张压(DBP)、糖尿病家族史、吸烟史、饮酒史、甘油三酯(TG)、高密度脂蛋白胆固醇(HDL-C)、载脂蛋白A1(ApoA1)、脂蛋白(a)[LP(a)]、纤维蛋白原(FIB)、纤维蛋白降解产物(FDP)比较无差异(P>0.05).以孕妇发生GDM作为因变量,以单因素分析中P<0.05的15个因素作为自变量,实施Logistic回归分析,结果显示:孕前BMI、FPG、TC、LDL-C、sdLDL、ApoE、HbA1c、D-D高为孕妇发生GDM的独立危险因素,INR、TT高为孕妇发生GDM的保护因素(P<0.05).ROC曲线分析显示:联合检测预测孕妇发生GDM的曲线下面积(AUC)为0.911,敏感度为88.94%,特异度为80.57%,与糖脂代谢指标(0.858、85.35%、74.32%)、凝血功能指标(0.742、78.59%、64.53%)单独检测相比更高.结论 孕前BMI、FPG、TC、LDL-C、sdLDL、ApoE、HbA1c、D-D高为孕妇发生GDM的独立危险因素,INR、TT高为孕妇发生GDM的保护因素;其中凝血、血糖、血脂等指标可作为孕妇发生GDM的预测因素,且联合预测价值更为理想.
Predictive value of glycolipid metabolism indicators and coagulation function indicators in early pregnancy for gestational diabetes mellitus
Objective To explore the predictive value of glycolipid metabolism indicators and coagulation function indicators in early pregnancy for gestational diabetes mellitus (GDM). Methods 126 pregnant women who underwent prenatal check ups were selected as the research subjects,and their baseline data and laboratory indicators were collected during the registration at 10-13 weeks' gestation,and they were categorized into the GDM group (n=31) and the non-GDM group (n=95) on the basis of the results of the Oral Glucose Tolerance Test (OGTT) at 24-28 weeks' gestation. The influencing factors of GDM were determined by univariate and multivariate Logistic regression analysis. Receiver operating characteristic (ROC) curve was drawn to analyze the predictive value of single and combined detection of glycolipid metabolism indicators and coagulation function indicators for GDM. Results In GDM group,the maternal age was (31.01±8.13) years,the pre-pregnancy body mass index (BMI) was (22.13±3.91) kg/m2,the gestational weight gain was (6.58±1.39) kg,the fasting plasma glucose (FPG) was (5.01±0.46) mmol/L,the total cholesterol (TC) was (5.33±1.11) mmol/L,the low-density lipoprotein cholesterol (LDL-C) was (3.96±1.28) mmol/L,the small dense low-density lipoprotein (sdLDL) was (418.33±16.47) mg/dl,the apolipoprotein B (ApoB) was (0.94±0.07) g/L,the apolipoprotein E (ApoE) was (44.35±1.04) mg/L,the glycosylated hemoglobin (HbA1c) was (8.83±0.52)%,and the D-dimer (D-D) was (0.53±0.04) mg/L,which were higher than (27.05±6.03) years,(20.76±3.02) kg/m2,(5.02±1.28) kg,(4.71±0.31) mmol/L,(4.92±0.79) mmol/L,(3.11±0.96) mmol/L,(341.25±14.08) mg/dl,(0.86±0.05) g/L,(40.05±1.52) mg/L,(5.54±0.63)%,and (0.49±0.03) mg/L in non-GDM group;the prothrombin time (PT) was (11.53±0.25) s,the international normalized ratio (INR) was (0.97±0.05),the activated partial thromboplastin time (APTT) was (26.89±1.74) s,and the prothrombin time (TT) was (15.42±0.17) s,which were lower than (11.97±0.29) s,(1.02±0.07),(28.11±1.83) s,and (15.88±0.19) s in non-GDM group (P<0.05). There was no difference in comparison of gestational week of registration,gestational week of OGTT test,number of deliveries,systolic blood pressure (SBP),diastolic blood pressure (DBP),family history of diabetes mellitus,history of smoking,history of alcohol consumption,triglyceride (TG),high-density lipoprotein cholesterol (HDL-C),apolipoprotein A1 (ApoA1),lipoprotein (a)[LP(a)],fibrinogen (FIB),fibrin degradation products (FDP) between the two groups (P>0.05). Logistic regression analysis was implemented with the occurrence of GDM in pregnant women as the dependent variable,and the 15 factors with P<0.05 in the univariate analysis as the independent variables,and the results showed that high pre-pregnancy BMI,FPG,TC,LDL-C,sdLDL,ApoE,HbA1c,and D-D were the independent risk factors for the occurrence of GDM in pregnant women,and high INR and TT were the protective factors (P<0.05). ROC curve analysis showed that the area under the curve (AUC) of combined detection in predicting the occurrence of GDM in pregnant women was 0.911,the sensitivity was 88.94%,and the specificity was 80.57%,which were higher than those of glycolipid metabolism indicators (0.858,85.35%,74.32%) and coagulation function indicators (0.742,78.59%,64.53%) alone. Conclusion High pre-pregnancy BMI,FPG,TC,LDL-C,sdLDL,ApoE,HbA1c,D-D are independent risk factors for the occurrence of GDM in pregnant women,and high INR,TT are protective factors for the occurrence of GDM in pregnant women;among them,coagulation,blood glucose,and lipids can be used as predictive factors for the occurrence of GDM in pregnant women,and the predictive value of combined detection is more ideal.

Early pregnancyGlycolipid metabolism indicatorsCoagulation function indicatorsGestational diabetesReceiver operating characteristic curve

张晖

展开 >

331500 江西省吉安市永丰县妇幼保健院检验科

妊娠早期 糖脂代谢指标 凝血功能指标 妊娠期糖尿病 受试者工作特征曲线

2024

中国实用医药
中国康复医学会

中国实用医药

影响因子:0.797
ISSN:1673-7555
年,卷(期):2024.19(23)